Summary
Epitope-Focused Vaccine Virus-like Particle
Classification
Description
Description
VLP Biotech development of epitope-focused vaccines. Our technology enables elicitation of robust antibody and CD4 T cell responses to defined protein regions. Our technology is suited for carbohydrate or other target conjugation.
Special details
Our virus-like particle platform is expressed in E. coli and self-assembles into a highly-stable, immunogenic particle.
Profile
-
Incorporated in
-
Established since2003
-
Main/BranchBranch
Address
-
State
-
County
-
City
-
Address3030 BUNKER HILL ST STE 117D
-
ZIP Code92109-5754
Contact
-
Phone
-
Email
-
Contact PersonDavid Whitacre